News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Articles|March 14, 2012

TRI_Imipramine

Antidepressants Tricyclics

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Latest CME

Optimizing Care for Patients With Tardive Dyskinesia

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Trending on Psychiatric Times

Partially Reversible Tinnitus Associated with Bupropion: A Case Highlighting the Importance of Dosage Adjustment

Exiting Antidepressants: A Needed Spotlight on Withdrawal

NDA Accepted and Priority Review Granted: Oveporexton for Narcolepsy Type 1

Antidepressant Withdrawal Syndromes: Listening to the Patient and Taking It Slow

Can AI Cure Medicine's Ills?